Opportunities and challenges for human papillomavirus vaccination in cancer

Nature Reviews. Cancer
R Roden, Peter Stern

Abstract

The discovery of genotype 16 as the prototype oncogenic human papillomavirus (HPV) initiated a quarter century of laboratory and epidemiological studies that demonstrated their necessary, but not sufficient, aetiological role in cervical and several other anogenital and oropharyngeal cancers. Early virus-induced immune deviation can lead to persistent subclinical infection that brings the risk of progression to cancer. Effective secondary prevention of cervical cancer through cytological and/or HPV screening depends on regular and widespread use in the general population, but coverage is inadequate in low-resource settings. The discovery that the major capsid antigen L1 could self-assemble into empty virus-like particles (VLPs) that are both highly immunogenic and protective led to the licensure of several prophylactic VLP-based HPV vaccines for the prevention of cervical cancer. The implementation of vaccination programmes in adolescent females is underway in many countries, but their impact critically depends on the population coverage and is improved by herd immunity. This Review considers how our expanding knowledge of the virology and immunology of HPV infection can be exploited to improve vaccine technologies and delivery...Continue Reading

References

Dec 15, 1992·Proceedings of the National Academy of Sciences of the United States of America·R KirnbauerJ T Schiller
Nov 1, 1994·Journal of Virology·R B RodenJ T Schiller
Feb 28, 1995·Proceedings of the National Academy of Sciences of the United States of America·S Jeon, P F Lambert
Dec 5, 1995·Proceedings of the National Academy of Sciences of the United States of America·J A SuzichR Schlegel
Aug 19, 1999·The Journal of Pathology·J M WalboomersN Muñoz
Apr 21, 2001·The Journal of Immunology : Official Journal of the American Association of Immunologists·P LenzJ T Schiller
Jun 5, 2002·Nature Reviews. Cancer·Harald zur Hausen
Nov 22, 2002·The Journal of Immunology : Official Journal of the American Association of Immunologists·Bryce ChackerianJohn T Schiller
Jun 9, 2004·Virology·Ethel-Michele de VilliersHarald zur Hausen
Sep 24, 2004·Proceedings of the National Academy of Sciences of the United States of America·Patricia M DayJohn T Schiller
Jan 25, 2006·Proceedings of the National Academy of Sciences of the United States of America·Rebecca M RichardsPatricia M Day
Aug 28, 2007·International Journal of Cancer. Journal International Du Cancer·Andreas M KaufmannAchim Schneider
Oct 12, 2007·Journal of Virology·Ratish GambhiraRichard B S Roden
Mar 28, 2008·Journal of Virology·Christopher B BuckBenes L Trus
Apr 17, 2008·Proceedings of the National Academy of Sciences of the United States of America·Hannah H AlphsRichard B S Roden
Feb 28, 2009·PLoS Pathogens·Dohun PyeonPaul F Lambert
Nov 19, 2009·Proceedings of the National Academy of Sciences of the United States of America·Rhonda C KinesPatricia M Day

❮ Previous
Next ❯

Citations

Oct 31, 2018·Biological Chemistry·Bastian BreinerClaudia Simon
Mar 19, 2019·Human Vaccines & Immunotherapeutics·Nitesh K KundaPavan Muttil
Apr 9, 2019·Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences·Irene ManJohannes A Bogaards
Oct 28, 2019·Frontiers in Immunology·Madhav V Dhodapkar, Kavita M Dhodapkar
Jan 1, 2020·Virology Journal·Pingdwende Kader Aziz BamogoSéverine Lacombe
Sep 5, 2018·European Journal of Oral Sciences·Stina Syrjänen
Dec 12, 2018·Expert Review of Vaccines·Paul Engeroff, Martin F Bachmann
Dec 14, 2018·Oncoimmunology·Lucillia BezuLorenzo Galluzzi
Apr 9, 2019·Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences·Till PiontekTim Waterboer
Jun 6, 2019·The Journal of Infectious Diseases·Johannes A BogaardsAudrey J King
Dec 4, 2019·Journal of Obstetrics and Gynaecology : the Journal of the Institute of Obstetrics and Gynaecology·N R ManyereZ M Chirenje
Aug 6, 2020·Frontiers in Immunology·Xu ZhouYang Lin
Aug 8, 2020·Molecular Biology Reports·Jie JiMing-Bing Xiao
Jul 23, 2020·Frontiers in Pharmacology·Chen QianHong Cui
Jul 28, 2020·Vaccines·Liqin ChengJuan Du
Apr 30, 2019·Frontiers in Plant Science·Silvia MassaAldo Venuti
Jan 28, 2020·The Journal of Infectious Diseases·Irene ManJohannes A Bogaards
Apr 4, 2020·Expert Review of Anti-infective Therapy·Ralph-Sydney Mboumba BouassaLaurent Bélec
May 21, 2020·Human Vaccines & Immunotherapeutics·Li Ping WongGregory D Zimet
Sep 5, 2018·The Journal of Clinical Investigation·Dongxue SuLei Shi
Nov 30, 2019·Biological Chemistry·Sandra Santos-Sierra
Feb 19, 2019·NPJ Vaccines·Robert E Hollingsworth, Kathrin Jansen
Dec 19, 2019·International Journal of Molecular Sciences·Nicole TrierGunnar Houen
Oct 8, 2020·Current Treatment Options in Oncology·Lennox Chitsike, Penelope Duerksen-Hughes
Jan 31, 2021·Revista colombiana de obstetricia y ginecología·Jorge Andrés Rubio-Romero, Luz Amparo Díaz-Cruz

❮ Previous
Next ❯

Methods Mentioned

BETA
enzyme-linked immunosorbent assay
ELISA

Software Mentioned

HPV
FASTER

Related Concepts

Related Feeds

Cancer Vaccines

Cancer vaccines are vaccines that either treat existing cancer or prevent development of a cancer.

Aphasia

Aphasia affects the ability to process language, including formulation and comprehension of language and speech, as well as the ability to read or write. Here is the latest research on aphasia.

Related Papers

Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences
Margaret Stanley
Infectious Disease Clinics of North America
Eileen F Dunne, Ina U Park
© 2022 Meta ULC. All rights reserved